Please provide your email address to receive an email when new articles are posted on . A blood test that predicts preterm birth risk, paired with targeted interventions, reduced neonatal morbidity ...
Investing.com -- Sera Prognostics Inc (NASDAQ:SERA) stock jumped 12% Wednesday after the company reported positive results from a large clinical trial of its PreTRM Test, which helps identify women at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results